Recall of multiple batches of the product ARANESP 500MCG/1ML PRE-FILLED SYRINGE
2026-08-05Product Description :
|
الاسم التجاري |
الاسم العلمي |
رقم التسجيل |
رقم التشغيلة المتأثرة |
الشركة الصانعة |
|
Trade Name |
Scientific Name |
Register Number |
Affected batch number |
Manufacturer |
|
ARANESP 500MCG/1ML PRE-FILLED SYRINGE |
DARBEPOETIN ALFA |
12-475-06 |
1189992A 1190934A |
AMGEN MANUFACTURING LIMITED, United States |
Issue :
SFDA has issued a recall of multiple batches of ARANESP 500 mcg/1 mL Pre-filled Syringe. The defect was identified as an Out-of-Specification (OOS) result, manifested by the presence of visible particles during the product's stability study at the 18-month stability time point. which may affect the quality and safety of the product.
Recommendations :
For healthcare professionals: Stop dispensing the batch immediately. Embargo/Quarantine all remaining stock. Affected batch should be returned to the supplier.
For patients,
- Consult your healthcare provider prior to discontinuing use of the affected batch, or for any health concerns.
- Contact the recalling firm or SFDA if you have any questions about the recall.
- Adverse reactions or quality problems experienced with the use of this product may be reported to Saudi Vigilance either online or call center (Call 19999).